Keros Therapeutics:Filed Prospectus Supplement to Co's Shelf Registration Statement for Issuance & Sale of up to $350 Mln Shares of Common Stock
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.